plx will get approved, spike like a mofo, then the market will immediately short the company as it struggles with commercialization realities and the smart money will go hand-over-fist into ibio simultaneously. PLX=Gateway Drug and is a necessary step in the process of a paradigm shift to plant-based platforms/methods and I hope it is successful. It's an interesting predicament really, in that IBIO will benefit greatly from the approval and success of PLX, only PLX will ultimately lag as a result of ibio's successes.
Julian Im in both stocks but I disagree that PLX will fall I believe they both will rise nicely and true value will be seen about a year from now when biosimilars go into play with 2013 regs is when IBIO will truly rocket. Im long both either way its the future.